Keywords: Merck KGaA, Merck Serono, Threshold Pharma, Pancreatic cancer

Merck KGaA licenses pancreatic cancer drug from Threshold

Article | 06 February 2012

Print This

Merck Serono, a division of German pharma and chemical major Merck KGaA (MRK: DE) has signed a global agreement with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in